Published in Inflamm Bowel Dis on July 01, 2010
Defective leukocyte GM-CSF receptor (CD116) expression and function in inflammatory bowel disease. Gastroenterology (2011) 1.73
Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy. J Interferon Cytokine Res (2015) 1.09
Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease. Inflamm Bowel Dis (2013) 0.96
Combined restitutive therapy for treatment of immunosuppressive refractory crohn disease. J Pediatr Gastroenterol Nutr (2015) 0.78
How does knowledge from translational research impact our clinical care of pediatric inflammatory bowel disease patients? Curr Gastroenterol Rep (2012) 0.77
Paediatric Crohn disease patients with stricturing behaviour exhibit ileal granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibody production and reduced neutrophil bacterial killing and GM-CSF bioactivity. Clin Exp Immunol (2013) 0.77
The role of the innate and adaptive immune system in pediatric inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.75
Human gut microbiome viewed across age and geography. Nature (2012) 19.31
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
Tofacitinib or adalimumab versus placebo in rheumatoid arthritis. N Engl J Med (2012) 4.85
Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet (2009) 3.82
A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone. Arthritis Rheum (2011) 3.44
Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr (2005) 3.37
Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet (2008) 3.36
Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol (2005) 3.34
Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology (2006) 3.32
Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology (2007) 2.96
Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center. Am J Gastroenterol (2003) 2.58
Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion. Arthritis Rheum (2002) 2.44
Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J Clin Invest (2014) 2.39
Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate. Arthritis Rheum (2004) 2.35
Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol (2009) 2.34
Risk factors for initial surgery in pediatric patients with Crohn's disease. Gastroenterology (2006) 2.22
Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's disease. Gastroenterology (2008) 2.21
ImproveCareNow: The development of a pediatric inflammatory bowel disease improvement network. Inflamm Bowel Dis (2011) 2.19
Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study. Arthritis Rheum (2013) 2.13
Challenges in meeting fellowship procedural guidelines in pediatric therapeutic endoscopy and liver biopsy. J Pediatr Gastroenterol Nutr (2014) 2.12
Increased immune reactivity predicts aggressive complicating Crohn's disease in children. Clin Gastroenterol Hepatol (2008) 2.09
Development of the gastrointestinal endoscopy competency assessment tool for pediatric colonoscopy (GiECAT KIDS). J Pediatr Gastroenterol Nutr (2014) 2.06
Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr (2005) 1.98
Endoscopic mucosal resection and endoscopic submucosal dissection. Gastrointest Endosc (2008) 1.95
Overtube use in gastrointestinal endoscopy. Gastrointest Endosc (2009) 1.94
Management of ingested magnets in children. J Pediatr Gastroenterol Nutr (2012) 1.78
Infliximab (REMICADE) therapy in the treatment of pediatric Crohn's disease. Am J Gastroenterol (2003) 1.77
Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr (2007) 1.74
Narrow band imaging and multiband imaging. Gastrointest Endosc (2008) 1.65
Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. Clin Gastroenterol Hepatol (2007) 1.64
Medication adherence and quality of life in pediatric inflammatory bowel disease. J Pediatr Psychol (2008) 1.60
Objective versus subjective assessment of oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis (2009) 1.59
Growth hormone treatment for growth failure in pediatric patients with Crohn's disease. J Pediatr (2008) 1.58
Minimizing occupational hazards in endoscopy: personal protective equipment, radiation safety, and ergonomics. Gastrointest Endosc (2010) 1.57
Infliximab in pediatric ulcerative colitis: two-year follow-up. J Pediatr Gastroenterol Nutr (2004) 1.55
A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm Bowel Dis (2005) 1.55
The gastrointestinal endoscopy competency assessment tool for pediatric colonoscopy. J Pediatr Gastroenterol Nutr (2015) 1.52
Polyethylene glycol powder solution versus senna for bowel preparation for colonoscopy in children. J Pediatr Gastroenterol Nutr (2013) 1.49
Challenges in pediatric inflammatory bowel disease. Inflamm Bowel Dis (2006) 1.49
Transition of the patient with inflammatory bowel disease from pediatric to adult care: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr (2002) 1.43
MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis. Gastroenterology (2013) 1.41
Predictors of immunomodulator use as early therapy in pediatric Crohn's disease. J Clin Gastroenterol (2006) 1.41
Magnet ingestion in children. J Pediatr Gastroenterol Nutr (2013) 1.39
Effects of prasterone on bone mineral density in women with systemic lupus erythematosus receiving chronic glucocorticoid therapy. J Rheumatol (2005) 1.37
Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale? Inflamm Bowel Dis (2007) 1.37
Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease. Clin Gastroenterol Hepatol (2006) 1.33
The natural history of corticosteroid therapy for ulcerative colitis in children. Clin Gastroenterol Hepatol (2006) 1.33
Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response. Gastroenterology (2010) 1.32
Inflammatory bowel disease in children 5 years of age and younger. Am J Gastroenterol (2002) 1.32
Large sample size, wide variant spectrum, and advanced machine-learning technique boost risk prediction for inflammatory bowel disease. Am J Hum Genet (2013) 1.31
Risk of early surgery for Crohn's disease: implications for early treatment strategies. Am J Gastroenterol (2003) 1.29
Oral glucocorticoid use is associated with an increased risk of fracture. Osteoporos Int (2004) 1.27
Variation in care in pediatric Crohn disease. J Pediatr Gastroenterol Nutr (2009) 1.26
Determinants of changes in linear growth and body composition in incident pediatric Crohn's disease. Gastroenterology (2010) 1.26
Patient and parent psychosocial factors associated with health-related quality of life in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2011) 1.25
Gender differences in body composition deficits at diagnosis in children and adolescents with Crohn's disease. Inflamm Bowel Dis (2007) 1.23
Disease activity, behavioral dysfunction, and health-related quality of life in adolescents with inflammatory bowel disease. Inflamm Bowel Dis (2010) 1.23
Inflammatory bowel disease: the difference between children and adults. Inflamm Bowel Dis (2008) 1.22
Genome-wide peripheral blood leukocyte DNA methylation microarrays identified a single association with inflammatory bowel diseases. Inflamm Bowel Dis (2012) 1.22
Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis (2009) 1.21
Management of ingested foreign bodies in children: a clinical report of the NASPGHAN Endoscopy Committee. J Pediatr Gastroenterol Nutr (2015) 1.21
Presentation and disease course in early- compared to later-onset pediatric Crohn's disease. Am J Gastroenterol (2008) 1.19
Appraisal of the pediatric ulcerative colitis activity index (PUCAI). Inflamm Bowel Dis (2009) 1.18
Gender differences in presentation and course of disease in pediatric patients with Crohn disease. Pediatrics (2007) 1.18
Intercenter variation in initial management of children with Crohn's disease. Inflamm Bowel Dis (2007) 1.17
Effect of early immunomodulator use in moderate to severe pediatric Crohn disease. Inflamm Bowel Dis (2008) 1.17
Efficacy and safety of retreatment in patients with rheumatoid arthritis with previous inadequate response to tumor necrosis factor inhibitors: results from the SUNRISE trial. J Rheumatol (2010) 1.17
Is an abbreviated Pediatric Crohn's Disease Activity Index better than the original? J Pediatr Gastroenterol Nutr (2004) 1.16
Age-specific questionnaires distinguish GERD symptom frequency and severity in infants and young children: development and initial validation. J Pediatr Gastroenterol Nutr (2005) 1.16
Capsule endoscopy of the colon. Gastrointest Endosc (2008) 1.16
Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN. Am J Gastroenterol (2011) 1.16
Growth abnormalities persist in newly diagnosed children with crohn disease despite current treatment paradigms. J Pediatr Gastroenterol Nutr (2009) 1.15
Outcome following infliximab therapy in children with ulcerative colitis. Am J Gastroenterol (2010) 1.14
A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum (2002) 1.14
Incidence of stricturing and penetrating complications of Crohn's disease diagnosed in pediatric patients. Inflamm Bowel Dis (2010) 1.14
Long-term outcome of maintenance infliximab therapy in children with Crohn's disease. Inflamm Bowel Dis (2009) 1.13
Shortcomings of the inflammatory bowel disease Serology 7 panel. Pediatrics (2010) 1.12
Human antichimeric antibody in children and young adults with inflammatory bowel disease receiving infliximab. J Pediatr Gastroenterol Nutr (2004) 1.11
Laboratory values for children with newly diagnosed inflammatory bowel disease. Pediatrics (2007) 1.10
Association of the T300A non-synonymous variant of the ATG16L1 gene with susceptibility to paediatric Crohn's disease. Gut (2007) 1.08
Inflammatory bowel disease in early childhood and adolescence: special considerations. Gastroenterol Clin North Am (2003) 1.08
Ultrathin endoscopes. Gastrointest Endosc (2010) 1.08